SMEInst-05-2016-2017
SMEInst-05-2016-2017
107 projects · €112,881,738 total EU contribution (project-level) · 108 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€112,881,738
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (15)
- Spain (13)
- France (11)
- Italy (10)
- SE (10)
- IL (8)
- Germany (7)
- Netherlands (6)
- PT (6)
- DK (4)
- IE (3)
- PL (3)
- AT (2)
- IS (2)
- NO (2)
- BE (1)
- CZ (1)
- EE (1)
- HU (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AENITIS TECHNOLOGIES2 projects · FR
- EBERS2 projects · ES
- THE ZEBRAFISH LAB2 projects · ES
- METAFORA BIOSYSTEMS2 projects · FR
- SYMCEL2 projects · SE
- 2CUREX A/S1 projects · DK
- 2CUREX GMBH1 projects · DE
- AMADIX1 projects · ES
- AEQUOR1 projects · UK
- AGLARIS1 projects · UK
- ALLTOX1 projects · IT
- ALTRATECH LIMITED1 projects · IE
Projects
Page 2 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Automated autologous cell therapy system Project ACT · 729171 | H2020 | €50,000 | €71,429 | Details |
Smart Biopsy Tool for Real-Time Cancerous Cell Characterization at the Tip of the Needle SmartGuide · 738529 | H2020 | €3,032,500 | €3,032,500 | Details |
Micro-tumor Guided Cancer Therapy Selection MicroCaT MicroCaT · 777718 | H2020 | €2,986,699 | €363,173 | Details |
Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies ADC · 729143 | H2020 | €50,000 | €71,429 | Details |
Cardiotoxicity High-throughput screening (HTS) with zebrafish embryo ZECARDIO · 755988 | H2020 | €1,867,186 | €1,867,186 | Details |
A next generation medical device that enhances patient care and treatment following colorectal surgery CG-100 · 762833 | H2020 | €50,000 | €71,429 | Details |
A scientifically proven, safe, naturally derived drug for the effective treatment of liver damage - an innovative solution for a significant unmet medical need SULIPRO · 763100 | H2020 | €50,000 | €71,429 | Details |
Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics MY FISH CURE · 735523 | H2020 | €50,000 | €71,429 | Details |
Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology BGCI · 763073 | H2020 | €50,000 | €71,429 | Details |
Healing Exosomes for sKIN HEXKIN · 744986 | H2020 | €50,000 | €71,429 | Details |